Johannes Gojo

7.1k citations
61 papers · 630 indexed · h-index 15
Topics
Glioma Diagnosis and Treatment (35 papers)Brain Metastases and Treatment (9 papers)Neuroblastoma Research and Treatments (8 papers)

In The Last Decade

Johannes Gojo

52 papers receiving 623 citations

Peers

Johannes Gojo
Comparison fields: 5 of 83
  • Molecular Biology 254
  • Genetics 229
  • Neurology 145
  • Oncology 116
  • Epidemiology 109
Replace Myra E. van Linde with:
Myra E. van Linde Netherlands
Semanti Mukherjee United States
Mirjam Hermisson Germany
Maryam Zarghooni Canada
Andrew Chi United States
Eva María Corrales-García Spain
Do Hyun Nam South Korea
Tracy Warr United Kingdom
Hiroko Kishikawa United States
Chelsea Mayoh Australia
Johannes Gojo relative to Myra E. van Linde Netherlands Myra E. van Linde's profile →
Citations per field
00.5×2.9×
Myra E. van Linde · 1×
Citations per year

Countries citing papers authored by Johannes Gojo

Since Specialization
Citations

This map shows the geographic impact of Johannes Gojo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johannes Gojo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johannes Gojo more than expected).

Fields of papers citing papers by Johannes Gojo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johannes Gojo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johannes Gojo. The network helps show where Johannes Gojo may publish in the future.

Co-authorship network of co-authors of Johannes Gojo

This figure shows the co-authorship network connecting the top 25 collaborators of Johannes Gojo. A scholar is included among the top collaborators of Johannes Gojo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johannes Gojo. Johannes Gojo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 8
4 0
5 1
6 1
7 0
8 1
9 2
10 8
11 2
12 7
13 12
14 16
15 38
16 22
17 29
18 7
19 23
20 19

About Johannes Gojo

Johannes Gojo is a scholar working on Genetics, Neurology and Structural Biology, having authored 61 papers that have together received 630 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (35 papers), Brain Metastases and Treatment (9 papers) and Neuroblastoma Research and Treatments (8 papers). The work is most often cited by research in Genetics (229 citations), Neurology (145 citations) and Cancer Research (102 citations). Johannes Gojo has collaborated with scholars based in Austria, Germany and Netherlands. Frequent co-authors include Andreas Peyrl, Irene Slavc, Thomas Czech, Walter Berger, Amedeo A. Azizi, Monika Chocholous, Christian Dorfer, Christine Haberler, Wolfgang Buchberger and Lisa Mayr. Their work appears in journals such as Cancer Research, International Journal of Cancer and Molecular Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026